Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion

OBJECTIVE: This study aimed to investigate the anatomical and functional changes in patients with central retinal artery occlusion (CRAO) (n=21) treated with 10 µg/day intravenous liposomal prostaglandin E1 (lipo-PGE1). METHODS AND ANALYSIS: We used best-corrected visual acuity (BCVA), central retin...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Takafumi, Obata, Ryo, Inoue, Tatsuya, Ueta, Yoshiki, Azuma, Keiko, Tate, Hideo, Kitamoto, Kohdai, Otaki, Chisato, Hashimoto, Yoshihiro, Aihara, Makoto, Tachi, Naoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134173/
https://www.ncbi.nlm.nih.gov/pubmed/36161847
http://dx.doi.org/10.1136/bmjophth-2022-001014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134173/
https://www.ncbi.nlm.nih.gov/pubmed/36161847
http://dx.doi.org/10.1136/bmjophth-2022-001014

Ejemplares similares